Stockholders’ Equity and Stock Option Plans (Tables)

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award

The following table summarizes stock option activity and related information under the Company’s equity incentive plans:

	Stock Options
	Number of Shares Underlying Outstanding Options	Weighted-Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands)
Outstanding — December 31, 2022	6,476,239	$	7.38	6.10	$	55,516
Options granted	1,313,004	15.40
Options exercised	(108,597)	2.88
Options canceled	(2,570)	6.14
Options expired	(15,538)	$	33.92
Outstanding — March 31, 2023	7,662,538	$	8.76	6.24	$	59,796
Vested and exercisable — March 31, 2023	5,245,258	$	5.27	5.23	$	53,940

The following table summarizes RSU activity and related information under the Company’s 2020 Plan:

	RSUs
	Number of Shares	Weighted-Average Grant Date Fair Value per Share
Unvested — December 31, 2022	1,581,982	$	26.49
Granted	2,049,867	$	16.07
Vested	(95,825)	$	29.92
Canceled/Forfeited	(26,512)	$	21.60
Unvested — March 31, 2023	3,509,512	$	20.35

Share-based Payment Arrangement, Expensed and Capitalized, Amount

otal stock-based compensation expense recognized in the condensed consolidated statements of operations was as follows (in thousands):

	Three Months Ended March 31,
	2023		2022
Cost of revenue	$	316	$	278
Technology and development	1,008		877
Sales and marketing	2,709		1,907
General and administrative	3,026		2,074
Total stock-based compensation expense	7,059		5,136
Tax benefit from stock-based compensation	(1,318)		(831)
Total stock-based compensation expense, net of tax effect	$	5,741	$	4,305